Singular Group acted as exclusive commercial advisor to NORD Holding on the majority investment in Material Analytischer Service (M.A.S.)
Singular Group congratulates NORD Holding UBG mbH on its recent majority investment in Material Analytischer Service (M.A.S.), a leading provider of customised parenteral test kits for visual inspection in the pharmaceutical industry. We are proud to have acted as the exclusive commercial advisor to NORD Holding on this great milestone.
M.A.S. is a German pioneer with >25 years of experience as a specialised laboratory service provider for the outsourced development and manufacturing of customised test kits, which are used as a reference standard for the manual and automatic visual inspection in the production of parenteral drugs.
With its high-quality test kits for pharmaceutical quality control and its exhaustive defect and particle library, M.A.S. is globally established as a preferred partner for big pharma, C(D)MOs, and automatic visual inspection machine manufacturers.
If you want to learn more about our buy- or sell-side commercial due diligence support in the B2B Technology space, please reach out to our responsible Partners Henriette Jemeljanow and Dennis Jung.
More info at: https://www.linkedin.com/posts/dennis-jung…
